FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34672111000001106: Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Sep 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104932901000001118 Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104933001000001110 Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets Is a Ticagrelor 90mg orodispersible tablets sugar free 56 tablet true Inferred relationship Existential restriction modifier
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets Has AMP Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) true Inferred relationship Existential restriction modifier
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets Has specific active ingredient Ticagrelor true Inferred relationship Existential restriction modifier
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start